{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:32:51Z","timestamp":1740123171552,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11033-022-07977-y","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:03:46Z","timestamp":1664492626000},"page":"11685-11693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-4627","authenticated-orcid":false,"given":"Ayad M.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaza F.","family":"Salih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"7977_CR1","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/ijms20184576","volume":"20","author":"X Yang","year":"2019","unstructured":"Yang X, Wong MPM, Ng RK (2019) Aberrant DNA methylation in acute myeloid leukemia and its clinical implications. Int J Mol Sci 20:4576. https:\/\/doi.org\/10.3390\/ijms20184576","journal-title":"Int J Mol Sci"},{"key":"7977_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/jcm5030033","volume":"5","author":"J Saultz","year":"2016","unstructured":"Saultz J, Garzon R (2016) Acute myeloid leukemia: a concise review. J Clin Med 5:33","journal-title":"J Clin Med"},{"key":"7977_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.31729\/jnma.5023","volume":"58","author":"N Maharjan","year":"2020","unstructured":"Maharjan N, Thapa N, Tu J (2020) Blood-based biomarkers for early diagnosis of lung cancer: a review article. J Nepal Med Assoc 58:519\u2013524","journal-title":"J Nepal Med Assoc"},{"issue":"2","key":"7977_CR4","doi-asserted-by":"publisher","first-page":"a030320","DOI":"10.1101\/cshperspect.a030320","volume":"7","author":"L Brunetti","year":"2017","unstructured":"Brunetti L, Gundry MC, Goodell MA (2017) DNMT3A in leukemia. Cold Spring Harb Perspect Med 7(2):a030320. https:\/\/doi.org\/10.1101\/cshperspect.a030320","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7977_CR5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368:2059\u20132074","journal-title":"N Engl J Med"},{"key":"7977_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0173-2","volume":"34","author":"R Berenstein","year":"2015","unstructured":"Berenstein R, Blau IW, Suckert N, Baldus C, Pezzutto A, D\u00f6rken B et al (2015) Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia. J Exp Clin Cancer Res 34:1\u201311","journal-title":"J Exp Clin Cancer Res"},{"key":"7977_CR7","doi-asserted-by":"publisher","first-page":"30395","DOI":"10.18632\/oncotarget.16449","volume":"8","author":"L Yang","year":"2017","unstructured":"Yang L, Liu Y, Zhang N, Ding X, Zhang W, Shen K et al (2017) Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs. Oncotarget 8:30395\u201330409","journal-title":"Oncotarget"},{"key":"7977_CR8","unstructured":"Pathogenesis ML (2021) The Role of Somatic Mutations in Acute; 1\u201324"},{"key":"7977_CR9","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1172\/JCI93041","volume":"127","author":"CB Cole","year":"2017","unstructured":"Cole CB, Russler-Germain DA, Ketkar S, Verdoni AM, Smith AM, Bangert CV et al (2017) Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. J Clin Invest 127:3657\u20133674","journal-title":"J Clin Invest"},{"key":"7977_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5473197","volume":"2017","author":"SF Chaudry","year":"2017","unstructured":"Chaudry SF, Chevassut TJT (2017) Epigenetic guardian: a review of the DNA methyltransferase DNMT3A in acute myeloid leukaemia and clonal haematopoiesis. Biomed Res Int 2017:1\u201313. https:\/\/doi.org\/10.1155\/2017\/5473197","journal-title":"Biomed Res Int"},{"key":"7977_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jclinpath-2016-204195","volume":"70","author":"M Tan","year":"2017","unstructured":"Tan M, Ng IKS, Chen Z, Ban K, Ng C, Chiu L et al (2017) Clinical implications of DNMT3A mutations in a Southeast Asian cohort of acute myeloid leukaemia patients. J Clin Pathol 70:669\u2013676","journal-title":"J Clin Pathol"},{"issue":"12","key":"7977_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41436-018-0003-y","volume":"20","author":"L Remacha","year":"2018","unstructured":"Remacha L, Curr\u00e1s-freixes M, Torres-ruiz R, Schiavi F, Torres-p\u00e9rez R, Calsina B et al (2018) Gain-of-function mutations in DNMT3A in patients with paraganglioma. Genet Med 20(12):1644\u20131651. https:\/\/doi.org\/10.1038\/s41436-018-0003-y","journal-title":"Genet Med"},{"key":"7977_CR13","volume-title":"Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis","author":"J Langstein","year":"2017","unstructured":"Langstein J, Milsom MD, Lipka DB (2017) Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis. Elsevier Ltd, Amsterdam"},{"key":"7977_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cell.2018.11.046","volume":"176","author":"S Gkountela","year":"2019","unstructured":"Gkountela S, Castro-giner F, Szczerba BM, Rochlitz C, Weber WP, Gkountela S et al (2019) Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding article circulating tumor cell clustering shapes DNA methylation. Cell 176:98-112.e14","journal-title":"Cell"},{"key":"7977_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/jcmm.13095","volume":"21","author":"S McPherson","year":"2017","unstructured":"McPherson S, McMullin MF, Mills K (2017) Epigenetics in myeloproliferative neoplasms. J Cell Mol Med 21:1660\u20131667","journal-title":"J Cell Mol Med"},{"key":"7977_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang X, Han H, DeCarvalho DD, Lay FD, Jones PA, Liang G (2014) Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26:577\u2013590","journal-title":"Cancer Cell"},{"key":"7977_CR17","doi-asserted-by":"publisher","first-page":"11355","DOI":"10.1093\/nar\/gkz911","volume":"47","author":"M Emperle","year":"2019","unstructured":"Emperle M, Adam S, Kunert S, Dukatz M, Baude A, Plass C et al (2019) Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns. Nucleic Acids Res 47:11355\u201311367","journal-title":"Nucleic Acids Res"},{"key":"7977_CR18","volume-title":"Epigenetic biomarkers and diagnostics","author":"F Zhao","year":"2016","unstructured":"Zhao F, Bapat B (2016) The role of methylation-specific PCR and associated techniques in clinical diagnostics. Epigenetic biomarkers and diagnostics. Elsevier Inc., Amsterdam"},{"key":"7977_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bcmd.2014.07.015","volume":"54","author":"L Ibrahem","year":"2015","unstructured":"Ibrahem L, Mahfouz R, Elhelw L, Abdsalam EM, Soliman R (2015) Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia. Blood Cells Mol Dis 54:84\u201389","journal-title":"Blood Cells Mol Dis"},{"key":"7977_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07545-4","author":"PMA Rashid","year":"2022","unstructured":"Rashid PMA, Salih GF (2022) Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq. Mol Biol Rep. https:\/\/doi.org\/10.1007\/s11033-022-07545-4","journal-title":"Mol Biol Rep"},{"issue":"1","key":"7977_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/pro.3746","volume":"29","author":"RA Laskowski","year":"2020","unstructured":"Laskowski RA, Thornton JM (2020) VarSite: disease variants and protein structure. Protein Sci 29(1):111\u2013119","journal-title":"Protein Sci"},{"key":"7977_CR22","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.ynpai.2022.100089","volume":"11","author":"E Rubino","year":"2022","unstructured":"Rubino E, Boschi S, Giorgio E, Pozzi E, Marcinn A, Gallo E et al (2022) Neurobiology of pain analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: an exploratory case-control study. Neurobiol Pain 11:100089. https:\/\/doi.org\/10.1016\/j.ynpai.2022.100089","journal-title":"Neurobiol Pain"},{"key":"7977_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41587-019-0041-2","volume":"37","author":"Y Liu","year":"2019","unstructured":"Liu Y, Siejka-Zieli\u0144ska P, Velikova G, Bi Y, Yuan F, Tomkova M et al (2019) Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol 37:424\u2013429","journal-title":"Nat Biotechnol"},{"key":"7977_CR24","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/leu.2014.124","volume":"28","author":"AP Im","year":"2014","unstructured":"Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE et al (2014) DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia 28:1774\u20131783","journal-title":"Leukemia"},{"key":"7977_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20202269","volume":"41","author":"A Aftab","year":"2021","unstructured":"Aftab A, Khan R, Shah W, Azhar M, Muhammad H, Hussain J et al (2021) Computational analysis of Cyclin D1 gene SNPs and association with breast cancer. Biosci Rep 41:1\u201323","journal-title":"Biosci Rep"},{"key":"7977_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jmoldx.2014.10.003","volume":"17","author":"M Mancini","year":"2015","unstructured":"Mancini M, Hasan SK, Ottone T, Lavorgna S, Ciardi C, Angelini DF et al (2015) Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn 17:179\u2013184","journal-title":"J Mol Diagn"},{"key":"7977_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1182\/blood-2011-07-369934","volume":"119","author":"HA Hou","year":"2012","unstructured":"Hou HA, Kuo YY, Liu CY, Chou WC, Lee MC, Chen CY et al (2012) DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood 119:559\u2013568","journal-title":"Blood"},{"issue":"1","key":"7977_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5045\/br.2020.55.1.17","volume":"55","author":"DJ Park","year":"2020","unstructured":"Park DJ, Kwon A, Cho B, Kim H, Hwang K, Kim M et al (2020) Characteristics of DNMT3A mutations in acute myeloid leukemia. Blood Res 55(1):17\u201326","journal-title":"Blood Res"},{"key":"7977_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00697-5","author":"M Liao","year":"2021","unstructured":"Liao M, Dong Q, Chen R, Xu L, Jiang Y, Guo Z et al (2021) Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis. Cell Death Discov. https:\/\/doi.org\/10.1038\/s41420-021-00697-5","journal-title":"Cell Death Discov"},{"issue":"2","key":"7977_CR30","doi-asserted-by":"publisher","first-page":"a030320","DOI":"10.1101\/cshperspect.a030320","volume":"7","author":"L Brunetti","year":"2017","unstructured":"Brunetti L, Gundry MC, Goodell MA (2017) DNMT3A in leukemia. Cold Spring Harb Perspect Med 7(2):a030320","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7977_CR31","first-page":"336","volume":"14","author":"F Ravandi-kashani","year":"2012","unstructured":"Ravandi-kashani F, Cortes JE, Kantarjian HM, Medeiros LJ, Luthra R (2012) Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis. JMDI 14:336\u2013345","journal-title":"JMDI"},{"key":"7977_CR32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/leu.2011.382","volume":"26","author":"A Renneville","year":"2012","unstructured":"Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C et al (2012) Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the acute leukemia French association. Leukemia 26:1247\u20131254","journal-title":"Leukemia"},{"key":"7977_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1200\/JCO.2011.39.2092","volume":"30","author":"G Marcucci","year":"2012","unstructured":"Marcucci G, Metzeler KH, Schwind S, Becker H, Maharry K, Mro\u017aek K et al (2012) Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol 30:742\u2013750","journal-title":"J Clin Oncol"},{"issue":"4","key":"7977_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/bjh.14823","volume":"179","author":"M Medinger","year":"2017","unstructured":"Medinger M (2017) Acute myeloid leukaemia genomics. Br J Haematol 179(4):530\u2013542","journal-title":"Br J Haematol"},{"key":"7977_CR35","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1093\/nar\/gky168","volume":"46","author":"M Emperle","year":"2018","unstructured":"Emperle M, Rajavelu A, Kunert S, Arimondo PB, Reinhardt R, Jurkowska RZ et al (2018) The DNMT3A R882H mutant displays altered flanking sequence preferences. Nucleic Acids Res 46:3130\u20133139","journal-title":"Nucleic Acids Res"},{"key":"7977_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-germain","year":"2014","unstructured":"Russler-germain DA, Spencer DH, Young MA, Lamprecht TL, Miller CA, Fulton R et al (2014) Article the R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25:442\u2013454","journal-title":"Cancer Cell"},{"key":"7977_CR37","first-page":"1","volume":"2014","author":"ECO Brien","year":"2014","unstructured":"Brien ECO, Prideaux S, Chevassut T (2014) The epigenetic landscape of acute myeloid leukemia. Adv Hematol 2014:1\u201315","journal-title":"Adv Hematol"},{"key":"7977_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.cell.2017.01.021","volume":"168","author":"DH Spencer","year":"2017","unstructured":"Spencer DH, Russler-germain DA, Ketkar S, Link DC, Dipersio JF, Ley TJ et al (2017) CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression article CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression. Cell 168:801-816.e13","journal-title":"Cell"},{"key":"7977_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0409-z","volume":"10","author":"Y Li","year":"2017","unstructured":"Li Y, Xu Q, Lv N, Wang L, Zhao H, Wang X et al (2017) Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. J Hematol Oncol 10:1\u201310","journal-title":"J Hematol Oncol"},{"key":"7977_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, R\u00f6thlisberger S (2017) Molecular biomarkers in acute myeloid leukemia. Blood Rev 31:63\u201376","journal-title":"Blood Rev"},{"key":"7977_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-020-00066-4","author":"IA Asfour","year":"2020","unstructured":"Asfour IA, Hegab HM, El-Salakawy WA, Hamza MT, Mansour DA, Saeed AM (2020) Prognostic significance of DNMT3a gene expression and reactive nitrogen species in newly diagnosed Egyptian de novo adult acute myeloid leukemia patients. Egypt J Med Hum Genet. https:\/\/doi.org\/10.1186\/s43042-020-00066-4","journal-title":"Egypt J Med Hum Genet"},{"key":"7977_CR42","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3324\/haematol.2018.197848","volume":"104","author":"J Bond","year":"2019","unstructured":"Bond J, Touzart A, Lepr\u00eatre S, Graux C, Lhermitte L, Hypolite G et al (2019) T-cell acute lymphoblastic leukemia. Haematologica 104:1617\u20131625","journal-title":"Haematologica"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07977-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07977-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07977-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:52:17Z","timestamp":1669837937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07977-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7977"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07977-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study protocol was approved by the Ethical Committee of the Sulaimania General Directorate of Health, Ministry of Health, Kurdistan Regional Government (KRG), Iraq (No. 9811; approved on 23\/08\/2021). Prior to participation in this study, the Declaration of Helsinki, which covers the ethical criteria for medical research involving human subjects, was also reviewed with each participant and the guardians of patients under the age of 18, who provided verbal and written consent. All investigations were carried out in accordance with relevant guidelines and regulations by university of Sulaimani, college of science (No. 1917\/259 on 01\/08\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}